Viscogliosi Brothers Acquisition Corp. (VBOC) operates as a blank check company, or special purpose acquisition company (SPAC), whose purpose is to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities; it focuses its search primarily on companies with operations in North America and Europe within the neuro-musculoskeletal industry, including implantable devices, services, regenerative medicine, and contract manufacturing sectors. Founded in 2020 and headquartered at 505 Park Avenue, 14th Floor, New York, NY, the company generates no revenue and conducts no active operations pending a business combination. It went public in January 2022, raising $75 million through an initial public offering of 7.5 million units at $10 each on Nasdaq (VBOC), with underwriters fully exercising an over-allotment option for additional proceeds of $11.25 million; however, it announced liquidation in July 2023 after failing to complete an initial business combination within the required timeframe and is now listed as an inactive instrument.